日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell-Engaging Antibody in GBM via Passive and Active Mechanisms.

纵向成像揭示了双特异性 T 细胞结合抗体在胶质母细胞瘤中通过被动和主动机制被肿瘤吸收和长期保留

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4194
Feng Yutian, Haupt Benedikt, Huynh Truc T, Meshaw Rebecca, Martin-Regalado Angela, Thakur Aditi, Duffy Joseph T, Alzeer Abdulaziz, Siegel David A, Barnes Ashlynn, Simberg Dmitri, Zalutsky Michael R, Balyasnikova Irina V
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A third generation PSMA-targeted agent [(211)At]YF2: Synthesis and in vivo evaluation

第三代PSMA靶向药物[(211)At]YF2：合成及体内评价

期刊:Nuclear Medicine and Biology
影响因子:3
doi:10.1016/j.nucmedbio.2024.108916
Feng, Yutian; Meshaw, Rebecca L; Finch, Sean W; Zheng, Yongxiang; Minn, Il; Vaidyanathan, Ganesan; Pomper, Martin G; Zalutsky, Michael R
发表日期：2024
文献求助 收藏

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose (211)At-Labeled Anti-HER2 Single-Domain Antibody Fragment

单剂量（211）At标记的抗HER2单域抗体片段有效治疗人乳腺癌异种移植瘤

期刊:
影响因子:
doi:10.2967/jnumed.122.264071
Feng, Yutian; Meshaw, Rebecca; Zhao, Xiao-Guang; Jannetti, Stephen; Vaidyanathan, Ganesan; Zalutsky, Michael R
Human
肿瘤
HER2
乳腺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent

使用新型残基修复剂对 HER2 靶向单域抗体片段进行位点特异性放射性卤化

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.2c01331
Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw, Ganesan Vaidyanathan, Mike A Cornejo, Brian M Zeglis, Michael R Zalutsky
HER2
发表日期：2022
文献求助 收藏

Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers

评估 131I 标记的 HER2 特异性单域抗体片段对 HER2 表达癌症的放射性药物治疗

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-022-07006-9
Yutian Feng, Rebecca Meshaw, Darryl McDougald, Zhengyuan Zhou, Xiao-Guang Zhao, Stephen A Jannetti, Robert E Reiman, Erica Pippen, Robin Marjoram, Jeffrey L Schaal, Ganesan Vaidyanathan, Michael R Zalutsky
肿瘤
发表日期：2022
文献求助 收藏

Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent - N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate

使用新型残留修复剂 - N-琥珀酰亚胺基 3-(1-(2-(2-(2-(2-[18F]氟乙氧基)乙氧基)乙氧基)乙基)-1H-1,2,3-三唑-4-基)-5-(胍基甲基)苯甲酸酯对单域抗体片段进行 18F 标记

期刊:Nuclear Medicine and Biology
影响因子:3.6
doi:10.1016/j.nucmedbio.2021.06.002
Zhengyuan Zhou, Darryl McDougald, Rebecca Meshaw, Irina Balyasnikova, Michael R Zalutsky, Ganesan Vaidyanathan
发表日期：2021
文献求助 收藏

Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent

用残留修复剂对抗 HER2 单域抗体片段进行位点特异性放射性碘标记

期刊:Nuclear Medicine and Biology
影响因子:3.6
doi:10.1016/j.nucmedbio.2020.05.002
Yutian Feng, Zhengyuan Zhou, Darryl McDougald, Rebecca L Meshaw, Ganesan Vaidyanathan, Michael R Zalutsky
HER2
发表日期：2021
文献求助 收藏

Site-Specific and Residualizing Linker for (18)F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

用于 (18)F 标记并增强肾清除率的位点特异性和残留连接子：应用于抗 HER2 单域抗体片段

期刊:
影响因子:
doi:10.2967/jnumed.120.261446
Zhou, Zhengyuan; Meshaw, Rebecca; Zalutsky, Michael R; Vaidyanathan, Ganesan
HER2
发表日期：2021
文献求助 收藏

Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.

新型患者来源的胰腺腺泡细胞癌异种移植小鼠模型显示奥沙利铂单药活性

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-016-0875-z
Hall Jason C, Marlow Laura A, Mathias Adam C, Dawson Louis K, Durham William F, Meshaw Kenneth A, Mullin Robert J, Synnott Aidan J, Small Daniel L, Krishna Murli, von Hoff Daniel, Schüler Julia, Hart Steven N, Couch Fergus J, Colon-Otero Gerardo, Copland John A
细胞生物学
Mouse
肿瘤免疫
发表日期：2016
文献求助 收藏

Systematic repurposing screening in xenograft models identifies approved drugs with novel anti-cancer activity

在异种移植模型中进行系统性药物重定位筛选，可发现具有新型抗癌活性的已批准药物。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0101708
Roix, Jeffrey J; Harrison, S D; Rainbolt, Elizabeth A; Meshaw, Kathryn R; McMurry, Avery S; Cheung, Peter; Saha, Saurabh
肿瘤
肿瘤免疫
发表日期：2014
文献求助 收藏